Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
bioAffinity Technologies, Inc. | 10%+ Owner | Common Stock, par value $0.007 | 328K | $2.21M | $6.75 | Sep 6, 2022 | Direct |
bioAffinity Technologies, Inc. | 10%+ Owner | Warrants (right to buy) | 47.9K | Jul 20, 2022 | Direct | ||
bioAffinity Technologies, Inc. | 10%+ Owner | Warrant (right to buy) | 23.8K | Sep 6, 2022 | Direct | ||
bioAffinity Technologies, Inc. | 10%+ Owner | Secured Convertible Promissory Note | 0 | Sep 6, 2022 | Direct | ||
bioAffinity Technologies, Inc. | 10%+ Owner | Series A Convertible Preferred Stock | 0 | Sep 6, 2022 | Direct | ||
bioAffinity Technologies, Inc. | 10%+ Owner | Unsecured Convertible Promissory Note | 0 | Sep 6, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
BIAF | bioAffinity Technologies, Inc. | Sep 6, 2022 | 12 | -$28.5K | 4 | Mar 7, 2023 | 10%+ Owner |
BIAF | bioAffinity Technologies, Inc. | Aug 29, 2022 | 0 | $0 | 3 | Mar 7, 2023 | 10%+ Owner |